[{"Assets_0_Q2_USD":787843000.0,"CommonStockSharesOutstanding_0_Q2_shares":41606082.0,"NetIncomeLoss_2_Q2_USD":-41000.0,"NetIncomeLoss_1_Q2_USD":2730000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":41312000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":41384000.0,"StockholdersEquity_0_Q2_USD":341650000.0,"EarningsPerShareBasic_1_Q2_USD":0.07,"EarningsPerShareBasic_2_Q2_USD":0.0,"Ticker":"PCRX","CIK":"1396814","name":"PACIRA BIOSCIENCES, INC.","OfficialName":"Pacira BioSciences Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3316489486.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]